Axsome Therapeutics
AXSM
35 hedge funds and large institutions have $32.6M invested in Axsome Therapeutics in 2017 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.
144% more call options, than puts
Call options by funds: $207K | Put options by funds: $85K
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
17% more funds holding
Funds holding: 30 → 35 (+5)
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
2% less capital invested
Capital invested by funds: $33.3M → $32.6M (-$674K)
2.58% less ownership
Funds ownership: 25.45% → 22.88% (-2.6%)
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.57M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.01M |
| 3 |
Millennium Management
New York
|
-$223K |
| 4 |
PAM
PVG Asset Management
Golden,
Colorado
|
-$104K |
| 5 |
Barclays
London,
United Kingdom
|
-$97K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Group One Trading
Chicago,
Illinois
| $38K | +$33.8K | +6,698 | New |
|
27
Morgan Stanley
New York
| $33K | +$9.59K | +1,900 | +47% |
|
28
Wells Fargo
San Francisco,
California
| $24K | +$11.1K | +2,200 | +110% |
|
|
MAM
29
Meeder Asset Management
Dublin,
Ohio
| $8K | +$2.62K | +519 | +62% |
|
|
CHP
30
Cable Hill Partners
Portland,
Oregon
| $6K | – | – | – |
|
|
LTFS
31
Ladenburg Thalmann Financial Services
Miami,
Florida
| $2K | – | – | – |
|
|
WAS
32
Winch Advisory Services
Appleton,
Wisconsin
| $2K | +$1.51K | +300 | New |
|
|
TRCT
33
Tower Research Capital (TRC)
New York
| $1K | +$1.24K | +245 | New |
|
34
BNP Paribas Financial Markets
Paris,
France
| $17 | – | – | – |
|
|
PAM
35
PVG Asset Management
Golden,
Colorado
| – | -$104K | -18,725 | Closed |
|
|
36
Barclays
London,
United Kingdom
| – | -$97K | -17,500 | Closed |
|
37
UBS Group
Zurich,
Switzerland
| – | -$1K | -240 | Closed |
|
38
Bank of America
Charlotte,
North Carolina
| – | -$1K | -226 | Closed |
|
39
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$81 | +16 | +533% |
|
AXSM Hedge Fund Activity: Q4 2017 in Review
35 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Axsome Therapeutics (AXSM) for Q4 2017, worth a combined $32.6M — down 2% from $33.3M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new AXSM positions and 4 closed out — a net gain of 5 holders — while 7 added to existing stakes and 6 trimmed.
The largest buyer was Alethea Capital Management, opening a new position worth an estimated $588K. The largest seller was Fidelity Investments, cutting an estimated $1.57M.
- 35 institutional investors held Axsome Therapeutics (AXSM) as of Q4 2017, up from 30 in Q3 2017.
- Funds reported $32.6M of Axsome Therapeutics stock for Q4 2017, down 2% quarter-over-quarter.
- 9 funds opened new Axsome Therapeutics positions in Q4 2017 and 4 closed out, a net change of +5 holders.
- The largest Axsome Therapeutics buyer in Q4 2017 was Alethea Capital Management, an estimated $588K added.
- The largest Axsome Therapeutics seller in Q4 2017 was Fidelity Investments, an estimated $1.57M sold.
Based on aggregated 13F filings for Q4 2017.